(Q28378496)

English

Disk diffusion susceptibility test development for the new glycylcycline, GAR-936

scientific article

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Disk diffusion susceptibility test development for the new glycylcycline, GAR-936 (English)

0 references

author name string

R N Jones

series ordinal

1

0 references

language of work or name

English

0 references

publication date

November 1999

0 references

published in

Diagnostic Microbiology and Infectious Disease

0 references

volume

35

0 references

issue

3

0 references

page(s)

249-52

0 references

cites work

In vitro activities of two glycylcyclines against gram-positive bacteria

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900090-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolates

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900090-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

N,N-dimethylglycyl-amido derivative of minocycline and 6-demethyl-6-desoxytetracycline, two new glycylcyclines highly effective against tetracycline-resistant gram-positive cocci

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900090-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro activity of DMG-Mino and DMG-DM Dot, two new glycylcyclines, against anaerobic bacteria

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900090-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936).

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900090-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Glycylcyclines. 1. A new generation of potent antibacterial agents through modification of 9-aminotetracyclines.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900090-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900090-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Susceptibility of enterococci, methicillin-resistant Staphylococcus aureus and Streptococcus pneumoniae to the glycylcyclines

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0732-8893%2899%2900090-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1016/S0732-8893(99)00090-5

0 references

PubMed publication ID

10626138

0 references

(Q28378496)

Disk diffusion susceptibility test development for the new glycylcycline, GAR-936

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)